{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:40:57Z","timestamp":1760100057973},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T00:00:00Z","timestamp":1208217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00520-008-0436-y","type":"journal-article","created":{"date-parts":[[2008,4,14]],"date-time":"2008-04-14T05:22:07Z","timestamp":1208150527000},"page":"1367-1374","source":"Crossref","is-referenced-by-count":8,"title":["Functional evaluation of conventional \u2018Celsite\u00ae\u2019 venous ports versus \u2018Vortex\u00ae\u2019 ports with a tangential outlet: a prospective randomised pilot study"],"prefix":"10.1007","volume":"16","author":[{"given":"G. A.","family":"Goossens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Verbeeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Moons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Sermeus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"De Wever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Stas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,15]]},"reference":[{"key":"436_CR1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/1097-0142(20010901)92:5<1204::AID-CNCR1439>3.0.CO;2-9","volume":"92","author":"R Biffi","year":"2001","unstructured":"Biffi R, De BF, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, Rotmensz N, Robertson C, Bellomi M, Andreoni B (2001) A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 92:1204\u20131212","journal-title":"Cancer"},{"key":"436_CR2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00520-004-0723-1","volume":"13","author":"J Caers","year":"2005","unstructured":"Caers J, Fontaine C, Vinh-Hung V, De Mey J, Ponnet G, Oost C, Lamote J, De Greve J, Van Camp B, Lacor P (2005) Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer 13:325\u2013331","journal-title":"Support Care Cancer"},{"key":"436_CR3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.amjsurg.2004.08.041","volume":"188","author":"JT Carlo","year":"2004","unstructured":"Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA (2004) A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. Am J Surg 188:722\u2013727","journal-title":"Am J Surg"},{"key":"436_CR4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/gyno.2001.6433","volume":"83","author":"DE Cohn","year":"2001","unstructured":"Cohn DE, Mutch DG, Rader JS, Farrell M, Awantang R, Herzog TJ (2001) Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies. Gynecol Oncol 83:533\u2013536","journal-title":"Gynecol Oncol"},{"key":"436_CR5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/112972980400500404","volume":"5","author":"GA Goossens","year":"2004","unstructured":"Goossens GA, Vrebos M, De Wever I, Stas M (2004) Vacutainer filling time through subcutaneous venous access devices. J Vasc Access 5:154\u2013160","journal-title":"J Vasc Access"},{"key":"436_CR6","first-page":"28","volume":"23","author":"L Goossens","year":"2005","unstructured":"Goossens L, J\u00e9r\u00f4me M, Stas M (2005) Verstopte poortkatheters: hoe vaak komt dit voor en wat doen verpleegkundigen hieraan? Oncologisch Tijdschrift 23:28\u201329","journal-title":"Oncologisch Tijdschrift"},{"key":"436_CR7","first-page":"54","volume":"21","author":"L Goossens","year":"2004","unstructured":"Goossens L, Vrebos M, Stas M, Rottiers L, Evers G (2004) De incidentie van verstopping, trombose, infectie en extravasatie bij subcutaan veneuze poortkatheters van oncologische pati\u00ebnten in Vlaamse ziekenhuizen. Een eerste analyse. Oncologisch Tijdschrift 21:54\u201359","journal-title":"Oncologisch Tijdschrift"},{"key":"436_CR8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jso.20264","volume":"91","author":"SM Hou","year":"2005","unstructured":"Hou SM, Wang PC, Sung YC, Lee HH, Liu HT, Chen YH (2005) Comparisons of outcomes and survivals for two central venous access port systems. J Surg Oncol 91:61\u201366","journal-title":"J Surg Oncol"},{"key":"436_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/107815529900500202","volume":"5","author":"F Krug","year":"1999","unstructured":"Krug F, Psathakis D, Hirsch U, Bruch H (1999) The K-port concept: proposal for optimising a fully implantable port system. J Oncol Pharm Practice 5:67\u201374","journal-title":"J Oncol Pharm Practice"},{"key":"436_CR10","first-page":"273","volume":"47","author":"F Lakdja","year":"1999","unstructured":"Lakdja F, Roubault N, Fonrouge JM (1999) [A new system for permanent venous access, Cathlink 20: prospective clinical study. 95 cases]. Pathol Biol (Paris) 47:273\u2013278","journal-title":"Pathol Biol (Paris)"},{"key":"436_CR11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/08998280.2003.11927932","volume":"16","author":"JP Lamont","year":"2003","unstructured":"Lamont JP, McCarty TM, Stephens JS, Smith BA, Carlo J, Livingston S, Kuhn JA (2003) A randomized trial of valved vs nonvalved implantable ports for vascular access. Proc Bayl Univ Med Cent 16:384\u2013387","journal-title":"Proc Bayl Univ Med Cent"},{"key":"436_CR12","first-page":"323","volume":"161","author":"G Lundberg","year":"1995","unstructured":"Lundberg G, Wahlberg E, Rickberg A, Olofsson P (1995) PAS-Port: a new implantable vascular access device for arm placement: experiences from the first two years. Eur J Surg 161:323\u2013326","journal-title":"Eur J Surg"},{"key":"436_CR13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1072-7515(00)00690-6","volume":"191","author":"VA Minassian","year":"2000","unstructured":"Minassian VA, Sood AK, Lowe P, Sorosky JI, Al-Jurf AS, Buller RE (2000) Longterm central venous access in gynecologic cancer patients. J Am Coll Surg 191:403\u2013409","journal-title":"J Am Coll Surg"},{"key":"436_CR14","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1200\/JCO.2006.05.8438","volume":"24","author":"S Moll","year":"2006","unstructured":"Moll S, Kenyon P, Bertoli L, De MJ, Homesley H, Deitcher SR (2006) Phase II trial of alfimeprase, a novel-acting fibrin degradation agent, for occluded central venous access devices. J Clin Oncol 24:3056\u20133060","journal-title":"J Clin Oncol"},{"key":"436_CR15","first-page":"706","volume":"92","author":"JE Niederhuber","year":"1982","unstructured":"Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706\u2013712","journal-title":"Surgery"},{"key":"436_CR16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9610(99)00124-5","volume":"178","author":"J Petersen","year":"1999","unstructured":"Petersen J, Delaney JH, Brakstad MT, Rowbotham RK, Bagley CM Jr. (1999) Silicone venous access devices positioned with their tips high in the superior vena cava are more likely to malfunction. Am J Surg 178:38\u201341","journal-title":"Am J Surg"},{"key":"436_CR17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1051-0443(07)61575-9","volume":"12","author":"D Ponec","year":"2001","unstructured":"Ponec D, Irwin D, Haire WD, Hill PA, Li X, McCluskey ER (2001) Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial\u2014the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. J Vasc Interv Radiol 12:951\u2013955","journal-title":"J Vasc Interv Radiol"},{"key":"436_CR18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00005792-198407000-00001","volume":"63","author":"OW Press","year":"1984","unstructured":"Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO (1984) Hickman catheter infections in patients with malignancies. Medicine (Baltimore) 63:189\u2013200","journal-title":"Medicine (Baltimore)"},{"key":"436_CR19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.1994.03510370066034","volume":"271","author":"II Raad","year":"1994","unstructured":"Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP (1994) The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271:1014\u20131016","journal-title":"JAMA"},{"key":"436_CR20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.RVI.0000127890.47187.91","volume":"15","author":"JC Schutz","year":"2004","unstructured":"Schutz JC, Patel AA, Clark TW, Solomon JA, Freiman DB, Tuite CM, Mondschein JI, Soulen MC, Shlansky-Goldberg RD, Stavropoulos SW, Kwak A, Chittams JL, Trerotola SO (2004) Relationship between chest port catheter tip position and port malfunction after interventional radiologic placement. J Vasc Interv Radiol 15:581\u2013587","journal-title":"J Vasc Interv Radiol"},{"key":"436_CR21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S1051-0443(07)61965-4","volume":"13","author":"CP Semba","year":"2002","unstructured":"Semba CP, Deitcher SR, Li X, Resnansky L, Tu T, McCluskey ER (2002) Treatment of occluded central venous catheters with alteplase: results in 1,064 patients. J Vasc Interv Radiol 13:1199\u20131205","journal-title":"J Vasc Interv Radiol"},{"key":"436_CR22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/ejso.2000.1047","volume":"27","author":"M Stas","year":"2001","unstructured":"Stas M, Mulier S, Pattyn P, Vijgen J, De Wever I (2001) Peroperative intravasal electrographic control of catheter tip position in access ports placed by venous cut-down technique. Eur J Surg Oncol 27:316\u2013320","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"436_CR23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2309\/108300800775897953","volume":"5","author":"B Stevens","year":"2000","unstructured":"Stevens B, Barton SE, Brechbill M, Moenter S, Piel AL, Shankle D (2000) A randomized, prospective trial of conventional vascular ports vs. the vortex \u201cclear-flow\u201d reservoir port in adult oncology patients. J Vasc Access Devices 5(4):37\u201340","journal-title":"J Vasc Access Devices"},{"key":"436_CR24","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1097\/01.CCM.0000142706.01717.EB","volume":"32","author":"P Svoboda","year":"2004","unstructured":"Svoboda P, Barton RP, Barbarash OL, Butylin AA, Jacobs BR, Lata J, Haire WD, Jaff MR, Firszt CM, Mouginis TL, Schuerr DM, Schulz GA, Schwartz LB, El-Shahawy MA (2004) Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial. Crit Care Med 32:1990\u20131996","journal-title":"Crit Care Med"},{"key":"436_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11239-006-0006-4","volume":"24","author":"P Verhamme","year":"2007","unstructured":"Verhamme P, Goossens G, Maleux G, Collen D, Stas M (2007) A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion. J Thromb Thrombolysis 24:1\u20135","journal-title":"J Thromb Thrombolysis"},{"key":"436_CR26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.RVI.0000071097.76348.72","volume":"14","author":"TM Vesely","year":"2003","unstructured":"Vesely TM (2003) Central venous catheter tip position: a continuing controversy. J Vasc Interv Radiol 14:527\u2013534","journal-title":"J Vasc Interv Radiol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-008-0436-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-008-0436-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-008-0436-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:01:47Z","timestamp":1559080907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-008-0436-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,15]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["436"],"URL":"https:\/\/doi.org\/10.1007\/s00520-008-0436-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,15]]}}}